Biopeptides Corp.
6Patents
6Active
6Granted
42Portfolio score
Filing activity: Jun 30, 2005 → Mar 12, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8821893B2 | Oral vaccine for Borrelia | Emerging Cross-Sectional Technologies | 12 | Active |
| US7887815B2 | Peptide diagnostic agent for lyme disease | Emerging Cross-Sectional Technologies | 11 | Active |
| US10983121B2 | Compositions and methods for diagnosing Lyme disease and for predicting Lyme disease spirochete elimination after treatment | Emerging Cross-Sectional Technologies | 1 | Active |
| US9816991B2 | Diagnostic peptides for lyme disease | Emerging Cross-Sectional Technologies | 1 | Active |
| US12066436B2 | Compositions and methods for diagnosing Lyme disease and for predicting Lyme disease spirochete elimination after treatment | Emerging Cross-Sectional Technologies | 0 | Active |
| US10006912B2 | Peptides for diagnosing lyme disease | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.